InsiderTrades

Form 4 for BKR Baker Hughes

Accepted 2025-02-14 00:00:00 ET · period of report 2025-02-12 · accession 0001701605-25-000051 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-02-14 2025-02-12 BKR Apostolides James E SVP, Enterprise Op Excellence S - Sale+OE $46.65 -7,681 19.6K -28% -$358.3K
D 2025-02-14 2025-02-12 BKR Apostolides James E SVP, Enterprise Op Excellence M - OptEx $36.89 +3,021 27.3K +12% +$111.4K
D 2025-02-14 2025-02-12 BKR Apostolides James E SVP, Enterprise Op Excellence M - OptEx $0.00 -3,021 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2025-02-12 S D 7,681 $46.65 19,596 D — —
2 Common Class A Common Stock 2025-02-12 M A 3,021 $36.89 27,277 D — —
3 Derivative Stock Option (Right to Buy) 2025-02-12 M D 3,021 $0.00 0 D $36.89 · 2018-07-31 to 2027-07-31 3,021 Class A Common Stock (F2) The stock option was granted on July 31, 2017 and vested in three equal installments beginning from the date of the grant.